Latest News
TIFIN, a fintech platform using AI for wealth and asset management, has held the successful closing of a USD47 million Series C funding round.
TIFIN uses data and investment driven intelligence to drive personalisation for wealth management, and digital distribution for investment managers. The firm closes its Series C round at a valuation that is nearly five times higher than its Series A which was completed towards the end of 2020. TIFIN’s mission is to make investing a more meaningful driver of financial well-being, by shaping the future of the investor experience. Through its focused divisions, Magnifi, a search-powered marketplace
Hinge Health, a digital musculoskeletal clinic, has secured USD400 million in a Series E financing, at a USD6.2 billion valuation. Tiger Global and Coatue Management led the round, with Alkeon and Whale Rock acquiring ownership as part of a USD200 million secondary investment.
“What makes this round special is that it’s led by the people who know us best – our existing investors,” says Daniel Perez, co-founder and CEO of Hinge Health. “We’ll use this capital to continue investing in new ways to improve access and outcomes, create exceptional patient experiences, and avoid unnecessary surgeries.”
Over USD1 billion has
BlueVoyant, the makers of an end-to-end internal and external cyber defence platform, has acquired 202 Group, a provider of data-driven supply chain risk management solutions to the US federal government.
This acquisition will combine the capabilities of BlueVoyant’s powerful cloud-native, third-party cyber risk management solution with 202 Group’s supply chain risk management solution to create a new offering, BlueVoyant Supply Chain Command™.
BlueVoyant Supply Chain Command is the most comprehensive supply chain risk management solution in the market with capabilities designed to manage strategic, cyber, operational, tactical, financial, and compliance risks.
“Simply put, there is nothing like this on the
New Water Capital, a private equity firm focused on lower-middle market companies, has acquired Nelson-Miller, a full-service provider of custom, engineered components and assemblies going into critical applications across medical, aerospace & defence and industrial end-markets.
Nelson-Miller will be New Water Capital’s newest platform investment, focused on serving the design, engineering and manufacturing needs of medical and industrial technologies, said New Water partner Brian McGee. “Our team sees huge market opportunity for companies such as Nelson-Miller that develop, produce and support the increasingly complex components used in a wide spectrum of today’s highly technical, essential products,” McGee says. “With its
BrainBox AI, a leader in autonomous building technology, today announced a USD24 million raise to further deploy its AI technology in the built environment and develop its next phase of innovation. The first close of its Series A round includes new lead investor, ABB, and investments by Esplanade Ventures and Desjardins Capital.
BrainBox AI offers predictive and self-adaptive artificial intelligence to optimise buildings’ energy usage, carbon footprint, and operational efficiency. To date, BrainBox AI has transformed over 100 million sq ft of building space across five continents by providing real estate asset owners with a scalable and impactful tool to
Summa Equity, which invests in companies solving global challenges, has been certified as a B Corporation, joining a growing group of companies reinventing business by pursuing purpose as well as profit.
The certification has been awarded by B Lab, the not-for-profit behind the B Corporation movement. Certified B Corporations are businesses that meet the highest standards of verified social and environmental performance, public transparency, and legal accountability to balance profit and purpose. B Corporations are accelerating a global culture shift to redefine success in business and build a more inclusive and sustainable economy.
“The B Corporation certification is a significant
Blockchain development platform Moralis has raised USD13.4 million in a seed funding round, led by EQT Ventures.
The funding will be used for hiring and continued product development, enabling developers to build enterprise-scale blockchain applications rapidly, cutting cost and complexity. By providing a complete, end-to-end blockchain application development platform, Moralis uniquely allows developers and companies to focus on the front-end while handling the entire back-end. This saves time and money for projects that don’t have the resources or teams to build, manage, and maintain complex blockchain infrastructure.
dApps exist and run on a blockchain, or peer-to-peer (P2P) network, of
According to the first estimates obtained by the Spanish Venture Capital & Private Equity Association (ASCRI) through the European platform EDC, the volume of investment in Spain reached EUR4,844 million in the third quarter of the year with a total of 618 investments, 18.4 per cent more than in the same period of 2020.
Venture Capital has surpassed all record highs, with EUR1,228 million in a total of 512 investments.
According to the type of investor, the investment appetite of international funds, both Private Equity and Venture Capital, which have abundant liquidity and maintain their interest in Spain, has
Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picodroplet technology, announced today that it has closed a USD40 million (circa GBP30 million) investment round.
The round was led by Sofinnova Partners (Paris, France) and Redmile Group (San Francisco, USA) co-investing on equal terms.
Sphere Fluidics will use the funding to enable the expansion of the Company’s international sales activities in key markets and improving its support for customers. Furthermore, it will expand its product research and development programs, including novel applications for its proprietary Cyto-Mine Single Cell Analysis System.
Pan Cancer T, a biotech spin-off from the Erasmus MC dedicated to the discovery and development of novel TCR-T therapies against solid tumours, has closed an extended seed investment round.
All current shareholders participated in the round, with Thuja Capital joining as a new investor. The undisclosed proceeds add to the initial seed capital financing announced earlier this year. The Company’s syndicate of experienced life science venture capital investors now includes Van Herk Ventures, Swanbridge Capital, and Thuja Capital as well as founding shareholder Erasmus MC.
Katrien Reynders-Frederix, CEO of Pan Cancer T, says: “Despite certain successes of adoptive
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
